8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      High incidence of discontinuations due to adverse events in patients treated with ceftaroline.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To determine clinical outcomes in patients who received ceftaroline (Teflaro) 600 mg intravenously every 8 or 12 hours after failing or developing intolerance to first-line agents including vancomycin, daptomycin, or linezolid.

          Related collections

          Author and article information

          Journal
          Pharmacotherapy
          Pharmacotherapy
          1875-9114
          0277-0008
          Jul 2014
          : 34
          : 7
          Affiliations
          [1 ] Department of Pharmacy, University of Washington Medical Center, Seattle, Washington; School of Pharmacy, University of Washington, Seattle, Washington.
          Article
          10.1002/phar.1435
          24807197
          © 2014 Pharmacotherapy Publications, Inc.

          Comments

          Comment on this article